Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Fotherby

Showing results (11-20 of 144) with videos related to

Pageof 15
Sort By:
BMJ (Clinical Research Ed.)|April 22, 1989
Oral contraceptives and lipidsK Fotherby
The Journal of Steroid Biochemistry and Molecular Biology|June 1, 1991
Intrasubject variability in the pharmacokinetics of ethynyloestradiolK Fotherby
Contraception|June 9, 1998
Metabolic interrelationships, cardiovascular disease, and sex steroidsK Fotherby
Contraception|August 1, 1996
Bioavailability of orally administered sex steroids used in oral contraception and hormone replacement therapyK Fotherby
Contraception|January 1, 1995
Twelve years of clinical experience with an oral contraceptive containing 30 micrograms ethinyloestradiol and 150 micrograms desogestrelK Fotherby
Clinical Pharmacokinetics|March 1, 1995
Levonorgestrel. Clinical pharmacokineticsK Fotherby
Annals of the New York Academy of Sciences|January 1, 1988
Interactions of contraceptive steroids with binding proteins and the clinical implicationsK Fotherby
Methods and Findings in Experimental and Clinical Pharmacology|January 1, 1982
Pharmacokinetics of ethynyloestradiol in humansK Fotherby
Advances in Contraception : the Official Journal of the Society for the Advancement of Contraception|December 1, 1987
A new oral contraceptive, FemovanK Fotherby
Contraceptive Delivery Systems|July 1, 1981
Factors affecting the duration of action of the injectable contraceptive norethisterone enanthateK Fotherby
Pageof 15

Showing results (11-20 of 144) with videos related to

Sort By:
Pageof 15
BMJ (Clinical Research Ed.)|April 22, 1989
Oral contraceptives and lipidsK Fotherby
The Journal of Steroid Biochemistry and Molecular Biology|June 1, 1991
Intrasubject variability in the pharmacokinetics of ethynyloestradiolK Fotherby
Contraception|June 9, 1998
Metabolic interrelationships, cardiovascular disease, and sex steroidsK Fotherby
Contraception|August 1, 1996
Bioavailability of orally administered sex steroids used in oral contraception and hormone replacement therapyK Fotherby
Contraception|January 1, 1995
Twelve years of clinical experience with an oral contraceptive containing 30 micrograms ethinyloestradiol and 150 micrograms desogestrelK Fotherby
Clinical Pharmacokinetics|March 1, 1995
Levonorgestrel. Clinical pharmacokineticsK Fotherby
Annals of the New York Academy of Sciences|January 1, 1988
Interactions of contraceptive steroids with binding proteins and the clinical implicationsK Fotherby
Methods and Findings in Experimental and Clinical Pharmacology|January 1, 1982
Pharmacokinetics of ethynyloestradiol in humansK Fotherby
Advances in Contraception : the Official Journal of the Society for the Advancement of Contraception|December 1, 1987
A new oral contraceptive, FemovanK Fotherby
Contraceptive Delivery Systems|July 1, 1981
Factors affecting the duration of action of the injectable contraceptive norethisterone enanthateK Fotherby
Pageof 15